We found that SC attenuates bile acid metabolism disorder in NASH mice by activating FXR signaling in the liver and intestine, contributing to the amelioration of steatosis, inflammation, and fibrosis in NASH mice. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatohepatitis.